View Item 

Show simple item record

A case of extravascular hemolysis with Tk‐activation
dc.contributor.authorYamada, Chisaen_US
dc.contributor.authorDavenport, Robertson D.en_US
dc.date.accessioned2014-09-03T16:51:31Z
dc.date.availableWITHHELD_12_MONTHSen_US
dc.date.available2014-09-03T16:51:31Z
dc.date.issued2014-08en_US
dc.identifier.citationYamada, Chisa; Davenport, Robertson D. (2014). "A case of extravascular hemolysis with Tk‐activation." Clinical Case Reports 2(4): 137-142.en_US
dc.identifier.issn2050-0904en_US
dc.identifier.issn2050-0904en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/108281
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherAABBen_US
dc.subject.otherPolyagglutinationen_US
dc.subject.otherTk‐Activationen_US
dc.subject.otherExtravascular Hemolysisen_US
dc.titleA case of extravascular hemolysis with Tk‐activationen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicineen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/108281/1/ccr380.pdf
dc.identifier.doi10.1002/ccr3.80en_US
dc.identifier.sourceClinical Case Reportsen_US
dc.identifier.citedreferenceLevene, N. A., C. Levene, K. Gekker, E. Sigler, H. Merhav, and A. Berrebi. 1990. Th polyagglutination with fatal outcome in a patient with massive intravascular hemolysis and perforated tumor of colon. Am. J. Hematol. 35: 127 – 128.en_US
dc.identifier.citedreferenceKlarkowski, D. B., and D. S. Ford. 1983. A case of polyagglutination with features of Th and Tk activation associated with an acquired B antigen. Transfusion 23: 59 – 61.en_US
dc.identifier.citedreferenceHorn, K. D. 1999. The classification, recognition and significance of polyagglutination in transfusion medicine. Blood Rev. 13: 36 – 44.en_US
dc.identifier.citedreferenceMeichenin, M., J. Rocher, O. Galanina, N. Bovin, N. Nifantev, A. Sherman, et al. 2000. Tk, a new colon tumore‐associated antigen resulting from altered O‐glycosylation. Cancer Res. 60: 5499 – 5507.en_US
dc.identifier.citedreferencePetz, L. D., and G. G. Garratty. 1980. P. 73 – 79 in Complement: a review for the immunohematologist. Alternative pathway of complement activation. Acquired immune hemolytic anemias. Churcill Livingstone Inc., London.en_US
dc.identifier.citedreferenceMarshall, P., A. Hasegawa, E. A. Davidson, V. Nussenzweig, and M. Whitlow. 1996. Interaction between complement proteins C5b‐7 and erythrocyte membrane sialic acid. J. Exp. Med. 184: 1225 – 1232.en_US
dc.identifier.citedreferenceDurocher, J. R., R. C. Payne, and M. E. Conrad. 1975. Role of sialic acid in erythrocyte survival. Blood 45: 11 – 20.en_US
dc.identifier.citedreferenceAminoff, D., W. F. Bruegge, W. C. Bell, K. Sarpolis, and R. Williams. 1977. Role of sialic acid in survival of erythrocytes in the circulation: interaction of neuraminidase‐treated and untreated erythrocytes with spleen and liver at the cellular level. Proc. Natl. Acad. Sci. USA 74: 1521 – 1524.en_US
dc.identifier.citedreferenceCrookston, K. P., A. P. Reiner, L. J. Cooper, R. A. Sacher, M. A. Blajchman, and N. M. Heddle. 2000. RBC T activation and hemolysis: implications for pediatric transfusion management. Transfusion 40: 801 – 812.en_US
dc.identifier.citedreferenceLevene, N. A., C. Levene, A. Dvilansky, and D. Buskila. 1986. T activation in a patient with T cell chronic lymphatic leukemia. Acta Haematol. 75: 122.en_US
dc.identifier.citedreferenceJudd, W. J., H. A. Oberman, and S. Flynn. 1982. Fatal intravascular hemolysis associated with T‐polyagglutination. Transfusion 22: 345 – 346.en_US
dc.identifier.citedreferenceHamilton, D. V., A. J. Black, J. Darnborough, and G. W. Bird. 1983. Haemolytic‐uraemic syndrome and T‐activation of red blood cells. Clin. Lab. Haematol. 5: 109 – 112.en_US
dc.identifier.citedreferenceHubl, W., B. Mostbeck, H. Hartleb, H. Pointner, K. Kofler, and P. M. Bayer. 1993. Investigation of the pathogenesis of massive hemolysis in a case of Clostridium perfringens septicemia. Ann. Hematol. 67: 145 – 147.en_US
dc.identifier.citedreferenceMoores, P., D. Pudifin, and P. L. Patel. 1975. Severe hemolytic anemia in an adult associated with anti‐T. Transfusion 15: 329 – 333.en_US
dc.identifier.citedreferenceMayer, B., S. Yurek, and A. Salama. 2010. Piperacillin‐induced immune hemolysis: new cases and a concise review of the literature. Transfusion 50: 1135 – 1138.en_US
dc.identifier.citedreferenceBandara, M., D. B. Seder, G. Garratty, R. M. Leger, and J. B. Zuckerman. 2010. Piperacillin‐induced immune hemolytic anemia in an adult with cystic fibrosis. Case Rep. Med. 2010: 161454.en_US
dc.identifier.citedreferenceLohiya, G. S., L. Tan‐Figueroa, and V. Krishna. 2011. Piperacillin‐induced immune hemolysis presenting with tachycardia and cardiac arrest. Case Rep. Med. 2011: 816497.en_US
dc.identifier.citedreferenceMarik, P. E., and P. Parekh. 2013. Life‐threatening piperacillin‐induced immune haemolysis in a patient with cystic fibrosis. BMJ Case Rep. 2012: 007801.en_US
dc.identifier.citedreferencePierce, A., and T. Nester. 2011. Pathology consultation on drug‐induced hemolytic anemia. Am. J. Clin. Pathol. 136: 7 – 12.en_US
dc.identifier.citedreferenceJudd, W. J., S. T. Johnson, and J. R. Storry. 2008. Investigating RBC polyagglutination. Pp. 559 – 569 in D. Blackall, R. J. Davey, S. T. Johnson, M. Lozano, B. C. McLeod, S. V. Rudmann, C. Sarkodee‐Adoo and J. W. Semple, eds. Judd's methods in immunohematology, 3rd ed.. AABB, Bethesda, MD.en_US
dc.identifier.citedreferenceDaniels, G. 2013. P. 515 – 523 in Polyagglutination and cryptantigens. Human Blood Groups. 3 rd ed. Wiley‐Blackwell, Hoboken, NJ.en_US
dc.identifier.citedreferenceMollison, P. L., C. P. Engelfriet, and M. Contreras. 2005. Red cell antibodies against self‐antigens, bound antigens and induced antigens. Pp. 277 – 284 in H. G. Klein, D. J. Anstee, eds. Mollison's blood transfusion in clinical medicine. 11 th ed. Blackwell publishing, Hoboken, NJ.en_US
dc.identifier.citedreferenceRamasethu, J., and N. Luban. 2001. T activation. Br. J. Haematol. 112: 259 – 263.en_US
dc.identifier.citedreferenceWilliams, R. A., E. F. Brown, D. Hurst, and L. C. Franklin. 1989. Transfusion of infants with activation of erythrocyte T antigen. J. Pediatr. 115: 949 – 953.en_US
dc.identifier.citedreferenceKlein, R. L., R. W. Novak, and P. E. Novak. 1986. T‐cryptantigen exposure in neonatal necrotizing enterocolitis. J. Pediatr. Surg. 21: 1155 – 1158.en_US
dc.identifier.citedreferenceRamasethu, J., and N. Luban. 2001. T activation. Br. J. Haematol. 112: 259 – 263.en_US
dc.identifier.citedreferenceBuskila, D., C. Levene, G. W. Bird, and N. A. Levene. 1987. Polyagglutination in hospitalized patients: a prospective study. Vox Sang. 52: 99 – 102.en_US
dc.identifier.citedreferenceEder, A. F., and C. S. Manno. 2001. Does red‐cell T activation matter? Br. J. Haematol. 114: 25 – 30.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ccr380.pdf
Size:
551.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.